TXT

TXT Shares Out (Diluted)

171.94MQuarterly

Period ending:

TXT FY Shares Out (Diluted)
TXT FY Shares Out (Diluted)1985-12-31: 293.73M1986-12-31: 324.13M1987-12-31: 322.07M1988-12-31: 349.03M1989-12-31: 354.04M1990-12-31: 354.34M1991-12-31: 438.82M1992-12-31: 352.71M1993-12-31: 455.66M1994-12-31: 362.71M1995-12-31: 347.73M1996-12-31: 342.86M1997-12-31: 338.60M1998-12-31: 334.33M1999-12-31: 309.16M2000-12-31: 292.30M2001-12-31: 285.87M2002-12-31: 280.50M2003-12-31: 274.43M2004-12-31: 280.34M2005-12-31: 272.89M2006-12-31: 260.44M2007-12-31: 254.83M2008-12-31: 250.34M2009-12-31: 262.92M2010-12-31: 302.56M2011-12-31: 307.26M2012-12-31: 294.66M2013-12-31: 284.43M2014-12-31: 281.79M2015-12-31: 278.73M2016-12-31: 272.37M2017-12-31: 268.75M2018-12-31: 253.24M2019-12-31: 228.00M2021-01-02: 226.40M2022-01-01: 216.90M2022-12-31: 214.97M2023-12-30: 201.77M2024-12-28: 190.31M2026-01-03: 180.26M455.66M0.00
1985-12-312026-01-03

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

TXT shares out (diluted) history

Weighted average diluted shares outstanding. The available annual fiscal periods series contains 41 observations from Dec 31, 1985 to Jan 3, 2026.

Textron Shares Out (Diluted) — Annual fiscal periods
Period endingShares Out (Diluted)
180,258,000
190,307,000
201,774,000
214,973,000
216,900,000
226,400,000
228,000,000
253,237,000
268,750,000
272,365,000
278,727,000
281,790,000
284,428,000
294,663,000
307,255,000
302,555,000
262,923,000
250,338,000
254,826,000
260,444,000
272,892,000
280,338,000
274,434,000
280,504,000
285,874,000
292,300,000
309,160,305
334,328,358
338,601,824
342,857,143
347,731,397
362,711,864
455,662,651
352,714,286
438,823,529
354,339,623
354,039,735
349,032,258
322,073,171
324,133,333
293,733,333

Compare shares out (diluted)

All TXT financial metrics · TXT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.